ContraFect Corp
Change company Symbol lookup
Select an option...
CFRX ContraFect Corp
NFLX Netflix Inc
LULU Lululemon Athletica Inc
NSC Norfolk Southern Corp
AMBA Ambarella Inc
BYND Beyond Meat Inc
AYX Alteryx Inc
ROKU Roku Inc
SHOP Shopify Inc
LKNCY Luckin Coffee Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin candidates includes CF-301, CF-302, CF-303, CF-309, CF-304, CF-305, CF-306, CF-307 and CF-308. Its other product candidate includes CF-404. Its lysin product candidate, CF-301 is developed for the treatment of Staph aureus bacteremia, including endocarditis, caused by methicillin-resistant Staph aureus and susceptible Staph aureus strains. Its product candidate, CF-404 is used for the treatment of human influenza, including seasonal and pandemic varieties. It focuses on addressing drug-resistant infections using product candidates from its lysin and monoclonal antibody platforms that target conserved regions of either bacteria or viruses.

Closing Price
$6.61
Day's Change
-0.35 (-5.03%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.08
Day's Low
6.57
Volume
(Light)
Volume:
315,010

10-day average volume:
561,016
315,010
  • Prev Close
    6.96
  • Today's Open
    6.90
  • Day's Range
    6.57-7.08
  • Avg Vol (10-day)
    561.0K
  • Last (time)
    4:00p ET 07/07/20
  • Last (size)
    100
  • 52-Wk Range
    2.69 - 13.40
    LowHigh
  • (08/29/19 - 01/13/20)
    145.45%
  • 117.4%
  • Market Cap
    183.8M
  • Shares Outstanding
    27.8M
  • -3.50
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 34.76
  • (% of float 06/15/20)
    3.63

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.